Safety and efficacy of allogeneic stem cell transplantation after nivolumab therapy for patients with relapsed/refractory classical Hodgkin lymphoma

被引：0
|
作者：
Beynarovich, A. [1 ]
Lepik, K. [2 ]
Mikhailova, N. [3 ]
Kondakova, E. [2 ]
Zalyalov, Y. [2 ]
Moiseev, I. [2 ]
Afanasyev, B. [2 ]
机构：
[1] Pavlov First St Petersburg State Med Univ, Raisa Gorbacheva Mem Res Inst Children Oncol Hema, St Petersburg, Russia
[2] Raisa Gorbacheva Mem Res Inst Children Oncol Hema, Hematol, St Petersburg, Russia
[3] Sci Res Inst Pediat Oncol Hematol & Transplantol, Raisa Gorbacheva Mem Res Inst Children Oncol Hema, St Petersburg, Russia
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
62P
引用
收藏
页码：22 / +
页数：2
相关论文
共 50 条
  • [41] The Outcomes of Nivolumab Fixed Dose 40 Mg Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
    Fedorova, Liudmila
    Lepik, Kirill
    Kotselyabina, Polina
    Kondakova, Elena
    Zalyalov, Yuri
    Borzenkova, Evgeniya
    Baykov, Vadim
    Epifanovskaya, Olga S.
    Babenko, Elena V.
    Moiseev, Ivan S.
    Kulagin, Aleksander
    Mikhailova, Natalia
    Afanasyev, Boris
    BLOOD, 2020, 136
  • [42] Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma
    Zhang, Chen
    Deng, Jili
    Xie, Yan
    Mi, Lan
    Liu, Weiping
    Wang, Xiaopei
    Zhao, Linjun
    Song, Yuqin
    Zhu, Jun
    CANCER MEDICINE, 2023, 12 (09): : 10351 - 10362
  • [43] Nivolumab is Effective in Relapsed Refractory Hodgkins Lymphoma Patient Following Mismatched Allogeneic Stem Cell Transplantation
    Browning, Amy Lynn
    Patel, Rushang D.
    Ahmed, Wesam
    Mori, Shahram
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S263 - S264
  • [44] Nivolumab for the treatment of relapsed and refractory classical Hodgkin lymphoma after ASCT and in ASCT-naive patients
    Lepik, Kirill V.
    Mikhailova, Natalia B.
    Moiseev, Ivan S.
    Kondakova, Elena V.
    Tsvetkova, Luibov A.
    Zalyalov, Yuri R.
    Borzenkova, Evgeniya S.
    Babenko, Elena V.
    Baykov, Vadim V.
    Markova, Inna V.
    Afanasyev, Boris V.
    LEUKEMIA & LYMPHOMA, 2019, 60 (09) : 2316 - 2319
  • [45] Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety
    Chan, Thomas S. Y.
    Khong, Pek-Lan
    Kwong, Yok-Lam
    ANNALS OF HEMATOLOGY, 2016, 95 (11) : 1913 - 1915
  • [46] Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety
    Thomas S. Y. Chan
    Pek-Lan Khong
    Yok-Lam Kwong
    Annals of Hematology, 2016, 95 : 1913 - 1915
  • [47] Allogeneic peripheral blood stem cell transplantation after reduced-intensity conditioning in refractory or relapsed Hodgkin lymphoma
    Alvarez, I
    Sureda, A
    Caballero, D
    Urbano, A
    Ribera, J
    Canales, M
    Hernández-Boluda, J
    Arranz, R
    Bernal, T
    de la Serna, J
    Diez, JL
    Moraleda, J
    Rubio-Félix, D
    Sierra, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S13 - S14
  • [48] Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma
    Kort, Jeries
    Chidiac, Amanda
    El Sayed, Rola
    Massoud, Radwan
    Nehme, Rita
    Bazarbachi, Ali
    El-Cheikh, Jean
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1732 - 1735
  • [49] A Cure Rate Survival Model after Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma Patients
    Mohseni, Navid
    Maboudi, Ali Akbar Khadem
    Baghestani, Ahmadreza
    Hajifathali, Abbas
    Saeedi, Anahita
    MIDDLE EAST JOURNAL OF CANCER, 2022, 13 (03) : 427 - 437
  • [50] Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation
    Kaloyannidis, Panayotis
    Hertzberg, Mark
    Webb, Kate
    Zomas, Athanasios
    Schrover, Rudolf
    Hurst, Michael
    Jacob, Ian
    Nikoglou, Thalia
    Connors, Joseph M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : 540 - 549
12345